Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, Min-Moon | - |
dc.contributor.author | Fok, Jie Shen | - |
dc.contributor.author | Thong, Bernard Yu-Hor | - |
dc.contributor.author | Yun, James | - |
dc.contributor.author | Li, Philip Hei | - |
dc.contributor.author | Kang, Hye-Ryun | - |
dc.contributor.author | Thien, Francis | - |
dc.contributor.author | Yamaguchi, Masao | - |
dc.contributor.author | Lucas, Michaela | - |
dc.contributor.author | Chang, Yoon-Seok | - |
dc.contributor.author | Kim, Byung-Keun | - |
dc.contributor.author | Nagao, Mizuho | - |
dc.contributor.author | Rengganis, Iris | - |
dc.contributor.author | Tsai, Yi-Giien | - |
dc.contributor.author | Chung, Wen-Hung | - |
dc.contributor.author | Rerkpattanapipat, Ticha | - |
dc.contributor.author | Kamchaisatian, Wasu | - |
dc.contributor.author | Leung, Ting Fan | - |
dc.contributor.author | Ho, Joo-Yoon | - |
dc.contributor.author | Zhang, Luo | - |
dc.contributor.author | Latiff, Amir Hamzah Abdul | - |
dc.contributor.author | Fujisawa, Takao | - |
dc.contributor.author | Castells, Mariana C. | - |
dc.contributor.author | Demoly, Pascal | - |
dc.contributor.author | Wang, Jiu Yao | - |
dc.contributor.author | Pawankar, Ruby | - |
dc.date.accessioned | 2021-08-30T13:02:42Z | - |
dc.date.available | 2021-08-30T13:02:42Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 2233-8276 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/52671 | - |
dc.description.abstract | Background: The issues and challenges in the diagnosis of drug allergy/hypersensitivity among children and adults in Asia are likely to be different from non-Asian countries. Objective: To study the diagnostic modalities used in the evaluation and management of drug allergy/drug hypersensitivity reactions (DHRs) among member societies of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Methods: A questionnaire comprising 41 questions was circulated electronically to member societies and individual members of APAAACI between January 23, 2020 and March 6, 2020. Results: Twenty-six respondents from 15 member societies and 1 individual member responded. European DHR guidelines were most commonly used. Skin prick and intradermal testing was used by 100%, with only 60% having access to commercial penicillin skin test reagents. In vitro-speci?c IgE tests were used by 75%, and basophil activation test by 56.3% for immediate DHR. Patch tests were used by 75% in contrast to lymphocyte transformation tests by 25% for nonimmediate DHR. Drug provocation tests were used by 68.8%, the most common indication being to exclude hypersensitivity where history/symptoms were not suggestive of drug hypersensitivity/allergy (93.3%). Human leukocyte antigen (HLA) genotype testing was mandatory among 25% respondents before new carbamazepine prescriptions, and 8.3% for allopurinol prescriptions. Conclusions: There was increased use of skin testing for iodinated contrast media hypersensitivity and patch testing for nonimmediate DHR. HLA genotype testing prior to new carbamazepine, allopurinol and abacavir prescriptions remain variable despite strong associations for severe cutaneous adverse reactions with Asian ethnicity. Results of this survey form a useful framework for developing educational and training needs and for improving access to drug allergy diagnostic and treatment modalities across APAAACI member societies. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ASIA PACIFIC ASSOC ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY | - |
dc.subject | SYNDROME/TOXIC EPIDERMAL NECROLYSIS | - |
dc.subject | COST-EFFECTIVENESS ANALYSIS | - |
dc.subject | HYPERSENSITIVITY REACTIONS | - |
dc.subject | BSACI GUIDELINES | - |
dc.subject | ALLERGY | - |
dc.subject | MANAGEMENT | - |
dc.subject | ALLOPURINOL | - |
dc.subject | CONSENSUS | - |
dc.subject | DESENSITIZATION | - |
dc.subject | ANAPHYLAXIS | - |
dc.title | Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Byung-Keun | - |
dc.identifier.doi | 10.5415/apallergy.2020.10.e36 | - |
dc.identifier.wosid | 000585970900002 | - |
dc.identifier.bibliographicCitation | ASIA PACIFIC ALLERGY, v.10, no.4 | - |
dc.relation.isPartOf | ASIA PACIFIC ALLERGY | - |
dc.citation.title | ASIA PACIFIC ALLERGY | - |
dc.citation.volume | 10 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.subject.keywordPlus | SYNDROME/TOXIC EPIDERMAL NECROLYSIS | - |
dc.subject.keywordPlus | COST-EFFECTIVENESS ANALYSIS | - |
dc.subject.keywordPlus | HYPERSENSITIVITY REACTIONS | - |
dc.subject.keywordPlus | BSACI GUIDELINES | - |
dc.subject.keywordPlus | ALLERGY | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | ALLOPURINOL | - |
dc.subject.keywordPlus | CONSENSUS | - |
dc.subject.keywordPlus | DESENSITIZATION | - |
dc.subject.keywordPlus | ANAPHYLAXIS | - |
dc.subject.keywordAuthor | Anaphylaxis | - |
dc.subject.keywordAuthor | Contrast media | - |
dc.subject.keywordAuthor | Penicillins | - |
dc.subject.keywordAuthor | Pharmacogenetics | - |
dc.subject.keywordAuthor | Skin tests | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.